###begin article-title 0
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
Two Estrogen Response Element Sequences Near the PCNA Gene Are Not Responsible for Its Estrogen-Enhanced Expression in MCF7 Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: CBK. Performed the experiments: CW JY. Analyzed the data: CW CBK. Contributed reagents/materials/analysis tools: CBK. Wrote the paper: CBK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 431 434 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 510 514 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
The proliferating cell nuclear antigen (PCNA) is an essential component of DNA replication, cell cycle regulation, and epigenetic inheritance. High expression of PCNA is associated with poor prognosis in patients with breast cancer. The 5'-region of the PCNA gene contains two computationally-detected estrogen response element (ERE) sequences, one of which is evolutionarily conserved. Both of these sequences are of undocumented cis-regulatory function. We recently demonstrated that estradiol (E2) enhances PCNA mRNA expression in MCF7 breast cancer cells. MCF7 cells proliferate in response to E2.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 125 132 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 254 262 246 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Here, we demonstrate that E2 rapidly enhanced PCNA mRNA and protein expression in a process that requires ERalpha as well as de novo protein synthesis. One of the two upstream ERE sequences was specifically bound by ERalpha-containing protein complexes, in vitro, in gel shift analysis. Yet, each ERE sequence, when cloned as a single copy, or when engineered as two tandem copies of the ERE-containing sequence, was not capable of activating a luciferase reporter construct in response to E2. In MCF7 cells, neither ERE-containing genomic region demonstrated E2-dependent recruitment of ERalpha by sensitive ChIP-PCR assays.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
We conclude that E2 enhances PCNA gene expression by an indirect process and that computational detection of EREs, even when evolutionarily conserved and when near E2-responsive genes, requires biochemical validation.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 163 166 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Waga1">[1]</xref>
###xml 178 181 174 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Umar1">[2]</xref>
###xml 198 201 194 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Maga1">[3]</xref>
###xml 203 206 199 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Warbrick1">[4]</xref>
###xml 326 329 322 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Waga2">[5]</xref>
###xml 354 357 350 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Chuang1">[6]</xref>
###xml 359 362 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Iida1">[7]</xref>
###xml 387 390 383 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hong1">[8]</xref>
###xml 392 395 388 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Moldovan1">[9]</xref>
###xml 397 401 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 489 493 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Baserga1">[10]</xref>
###xml 582 586 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 704 708 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Li1">[11]</xref>
###xml 709 713 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Alder1">[14]</xref>
The proliferating cell nuclear antigen (PCNA) gene product is a nuclear protein that acts as a cofactor for DNA polymerase-delta and participates in DNA synthesis [1] and repair [2](for reviews see [3], [4]). In addition, by interacting with a wide array of proteins, PCNA serves essential functions in cell cycle progression [5], epigenetic inheritance [6], [7], and gene transcription [8], [9]. PCNA gene expression is generally low in quiescent cells, increases with cell proliferation [10], and is tightly controlled within the cell cycle. In response to proliferative stimuli, PCNA mRNA and protein levels both increase during the G1/S transition, commensurate the protein's role in DNA replication [11]-[14].
###end p 9
###begin p 10
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Jaskulski1">[15]</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Almendral1">[16]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-ShipmanAppasamy1">[17]</xref>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Morris2">[18]</xref>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Kannabiran1">[19]</xref>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Baserga1">[10]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-ShipmanAppasamy1">[17]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Chang1">[20]</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Koniecki1">[21]</xref>
###xml 442 446 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
PCNA synthesis is induced by diverse stimuli in a cell-type specific fashion, including: EGF, PDGF, and serum in 3T3 cells [15], [16], interleukin 2 (IL-2) in T-lymphocytes [17], and p53 [18] and adenovirus infection in HeLa cells [19]. There appear to be transcriptional and post-transcriptional mechanisms for regulating PCNA mRNA levels in 3T3 cells by processes that are not fully characterized [10], [17], [20], [21]. No formal study of PCNA gene regulation has been demonstrated in breast cancer cells.
###end p 10
###begin p 11
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Schimmelpenning1">[22]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Kato1">[28]</xref>
###xml 506 510 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Yager1">[29]</xref>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
Most studies have observed that high PCNA gene expression correlates with increased metastatic potential and decreased survival in patients with breast carcinoma [22]-[28]. Many breast and uterine cancers depend upon E2 for neoplastic initiation, development, or metastasis, and antiestrogen therapies remain the mainstay of treatment and prevention for ERalpha-expressing breast cancers. The E2 response in breast cancer cells is predominantly mediated by ERalpha, a ligand-activated transcription factor [29].
###end p 11
###begin p 12
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 150 154 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Frasor1">[30]</xref>
###xml 156 160 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 263 267 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 365 368 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 426 430 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Bourdeau1">[32]</xref>
###xml 493 497 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-SchultzNorton1">[33]</xref>
###xml 511 515 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Martin1">[34]</xref>
###xml 671 675 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 799 803 771 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 308 314 <span type="species:ncbi:10090">murine</span>
###xml 319 324 <span type="species:ncbi:9606">human</span>
We confirmed that PCNA gene expression is enhanced by E2 exposure in MCF7 breast cancer cells which express ERalpha and proliferate in response to E2 [30], [31]. We, and others, have detected two putative estrogen response elements (EREs) in the 5' region of the PCNA gene, one of which is conserved between murine and human species, and both of which may serve as cis-regulatory elements for ERalpha-mediated gene regulation [32]. Recently, PCNA was shown to physically interact with ERalpha [33] and RARalpha [34] and to modulate gene transcription regulated by these transcription factors. These observations raise the possibility that E2-stimulated ERalpha activates PCNA gene expression, leading to feedback regulation of ERalpha transcriptional functions by ERalpha-bound PCNA. The process of PCNA gene induction is likely to be essential to the mitogenic effects of E2 in some ERalpha-expressing cancers.
###end p 12
###begin p 13
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Labrie1">[35]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Kannabiran2">[36]</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Labrie2">[37]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Liu1">[38]</xref>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Lee1">[39]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Lee2">[40]</xref>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Morris2">[18]</xref>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Kannabiran1">[19]</xref>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Krieg1">[41]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Li1">[11]</xref>
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Tommasi1">[12]</xref>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Tommasi1">[12]</xref>
###xml 361 365 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 501 504 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 578 582 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 584 588 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Spilianakis1">[42]</xref>
###xml 589 593 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Nunez1">[45]</xref>
###xml 732 736 728 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 986 990 982 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 1066 1070 1062 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
The PCNA promoter is regulated at the transcriptional level by many transcription factors including E1A [35], [36], ATF1 [37], RFX1 [38], CBP [39], p107 [40], p53 [18], [19], [41], and E2F [11], [12]. In some systems, basal transcription is augmented at G1/S by inducible regulatory elements [12]. No role for ERalpha has been demonstrated in the regulation of PCNA gene expression although estrogens act as potent mitogens in both normal and neoplastic breast and uterine tissues. Because eukaryotic cis-regulatory elements may reside great genomic distances from target genes [31], [42]-[45], and because the putative EREs that we identified are located 1,200-10,000 bp from either transcription start site (TSS) demonstrated for PCNA, we thought it important to test these elements for functional significance. Our goals were to understand the predictive value of computational ERE detection for an E2-responsive gene and to better define the mechanisms by which estrogen stimulates PCNA gene expression in breast cancer cells. Our data indicate that E2 enhances PCNA gene expression by an indirect process and that computational detection of EREs, even when evolutionarily conserved and when near E2-responsive genes, requires biochemical validation.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
E2 stimulated PCNA mRNA and protein expression in a process that requires de novo protein synthesis
###end title 15
###begin p 16
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 264 268 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 391 395 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 408 413 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 534 538 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Bourdeau1">[32]</xref>
###xml 469 474 <span type="species:ncbi:9606">human</span>
###xml 479 484 <span type="species:ncbi:10090">mouse</span>
###xml 628 633 <span type="species:ncbi:9606">human</span>
###xml 693 698 <span type="species:ncbi:10090">mouse</span>
We recently reported the results of microarray-based gene expression profiling using the MCF7 breast cancer cell line, a model system for E2-dependent breast tumors [31]. MCF7 cells express ERalpha and proliferate in response to E2 exposure. We observed increased PCNA gene expression after 4, 12, and 24 hours of E2 exposure. Notably, two putative EREs were previously detected upstream of PCNA by Bourdeau et al, who applied large scale computational analyses to the human and mouse genomes for detection of conserved ERE sequences [32]. Our analysis revealed that the both ERE sequences are 100% conserved between Rhesus and human, whereas the 3'-ERE sequence also shares 79% identity with mouse, indicating that the 3'-ERE is more evolutionarily conserved. These ERE sequences were never tested for function.
###end p 16
###begin p 17
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 191 200 191 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g001">Figure 1A</xref>
###xml 249 264 249 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFF1, MYC, STC2</italic>
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCC1.</italic>
###xml 363 372 363 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g001">Figure 1B</xref>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 581 590 581 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g001">Figure 1A</xref>
###xml 967 971 967 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Blow1">[46]</xref>
Quantitative reverse transcription polymerase chain reaction (Q-RT-PCR) was applied to MCF7 cell lysates and confirmed greater than 2-fold induction of PCNA mRNA after six hours E2 exposure (Figure 1A). Known E2-responsive genes also tested include TFF1, MYC, STC2, and DCC1. Similar changes in PCNA protein levels were observed after E2 treatment of MCF7 cells (Figure 1B). The E2-stimulated expression of PCNA mRNA was sensitive to co-treatment with the protein synthesis inhibitor cycloheximide (CHX), suggesting a secondary, or indirect, transcriptional effect of E2 exposure (Figure 1A). Interestingly, DCC1, a component of the replication factor C (RFC) which loads PCNA onto DNA during DNA replication, demonstrated expression that was similarly E2 responsive and CHX sensitive. These data are consistent with a model in which DNA replication is regulated within the cell cycle, in part, by the regulated synthesis and degradation of the replicative machinery [46].
###end p 17
###begin title 18
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
Estrogen stimulates PCNA mRNA and protein expression in MCF7 cells.
###end title 18
###begin p 19
###xml 225 240 221 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFF1, MYC, STC2</italic>
###xml 246 250 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCC1</italic>
###xml 284 288 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 293 297 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCC1</italic>
(A) MCF7 cells were treated for six hours with or without E2 (100 nM) and with or without CHX (25 microg/ml), an inhibitor of protein synthesis. RNA was collected and subjected to Q-RT-PCR. Known E2-responsive genes included TFF1, MYC, STC2, and DCC1. The E2-stimulated expression of PCNA and DCC1 was lost when cells were co-treated CHX. Values are the average of three experiments, performed in triplicate, with SEM indicated. (B) PCNA protein levels were measured from MCF7 cell lysates by Western blot after 0, and 24 hours of E2 (10 nM) exposure. Results using ACTIN-specific antibody on the same lysates are also shown. The data are representative of an experiment performed twice. * P < 0.02 comparing control with E2-treated.
###end p 19
###begin p 20
###xml 67 74 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 190 195 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 242 246 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Weisz1">[47]</xref>
###xml 248 252 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Weisz2">[48]</xref>
###xml 261 268 253 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 331 336 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fos</italic>
###xml 382 386 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Bourdeau2">[49]</xref>
###xml 509 513 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Carroll1">[44]</xref>
###xml 539 543 527 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
There exist direct transcriptional targets of ERalpha that require de novo protein synthesis in order to be transcriptionally regulated by the receptor. For example, the ERalpha gene target c-fos is rapidly activated by E2 in uterine tissues [47], [48] whereas de novo protein synthesis is required in order to produce a sustained c-fos transcriptional response to E2 in MCF7 cells [49]. Similarly, there exist gene targets that are repressed by ERalpha only after induction of the corepressor protein NRIP-1 [44]. Thus, the fact that the PCNA response to E2 was CHX-sensitive did not preclude the gene from being a direct responder to ERalpha.
###end p 20
###begin title 21
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
E2-enhanced PCNA gene expression was blocked by inhibition of ERalpha function
###end title 21
###begin p 22
###xml 168 172 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Bouras1">[50]</xref>
###xml 174 178 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Frasor2">[51]</xref>
###xml 227 231 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 345 353 337 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g002">Figure 2</xref>
###xml 390 393 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 475 479 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Dubik1">[52]</xref>
###xml 534 538 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 597 604 581 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
Blocking an E2-mediated transcriptional response by co-treatment with ICI 182,780, a pure ERalpha antagonist, indicates that the observed effect is mediated by ERalpha [50], [51]. In MCF7 cells, the E2-stimulated expression of PCNA was blocked by co-treatment with ICI 182,170 and by inhibition of gene transcription using actinomycin D (ActD) (Figure 2). Similar results were observed for MYC gene expression, which is also E2-responsive and a direct gene target of ERalpha [52]. These data support the hypothesis that E2-stimulated PCNA gene expression requires both the activity of ERalpha and de novo gene transcription.
###end p 22
###begin title 23
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 62 69 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
Estrogen-stimulated PCNA gene expression requires ERalpha and de novo gene transcription.
###end title 23
###begin p 24
###xml 262 266 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 298 301 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
MCF7 cells were treated with or without E2 (100 nM) for 6 hours. Additional treatments included ActD (2 microg/ml), an inhibitor of gene transcription, and ICI 182,780 (1 microM), a pure estrogen receptor antagonist. RNA was collected and subjected to Q-RT-PCR. PCNA mRNA levels were compared with MYC mRNA levels from the same samples. Values are the average of three experiments, performed in triplicate, with SEM indicated. * P < 0.05 comparing control with E2-treated.
###end p 24
###begin p 25
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 391 400 391 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g003">Figure 3A</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Tommasi1">[12]</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-ShipmanAppasamy1">[17]</xref>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Klinge1">[53]</xref>
###xml 774 778 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Loven1">[57]</xref>
###xml 961 965 953 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 967 971 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Carroll2">[58]</xref>
###xml 1262 1267 1254 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1354 1358 1342 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Laganiere1">[59]</xref>
###xml 637 642 <span type="species:ncbi:9606">human</span>
We recently demonstrated that siRNA-mediated knockdown of PCNA gene expression greatly inhibited E2-stimulated cell proliferation in MCF7 cells [31]. These data supported the hypothesis that PCNA is an important mediator of E2-stimulated cell proliferation in MCF7 cells. Our analysis of the PCNA gene locus confirmed two imperfect ERE's within 10 Kb of the two TSSs described for the gene (Figure 3A) [12], [17]. Each putative ERE (herein dubbed PCNA-ERE1 and PCNA-ERE2) demonstrates a single nucleotide mismatch from the core 13 bp consensus (or "canonical") ERE sequence. Notably, the majority of EREs identified and validated in the human genome do not demonstrate perfect consensus sequences, indicating a high degree of heterogeneity for functional ERE sequences [53]-[57]. Similarly, the mere presence of an ERE-like sequence is not sufficient to ensure ERalpha binding or ERalpha-mediated transcriptional responses in the majority of chromatin contexts [31], [58]. These observations indicate that ERE sequences must combine with additional factors in order to function. Such factors may include regional histone composition, distribution, and post-translational histone modifications, DNA methylation status, and regional DNA sequences (with associated trans-factors) that create a transcriptionally permissive environment for activated ERalpha [59].
###end p 25
###begin title 26
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 61 70 57 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro.</italic>
Two EREs reside near the TSSs for PCNA, one binds to ERalpha in vitro.
###end title 26
###begin p 27
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
(A) Genomic sequences of two EREs, the 5'-ERE (PCNA-ERE1) and the 3'-ERE (PCNA-ERE2), are indicated, with associated distances from the 3' transcription start site (TSS) of the PCNA gene. Deviations from the consensus ERE sequence are indicated in lower case. Previously-described regulatory regions are similarly indicated (see main text). (B) EMSA was performed using HESC cell nuclear lysates plus recombinant ERalpha (rERalpha) and radiolabeled consensus ERE or PCNA-ERE1 probes. The ERalpha-containing complex (arrow) is demonstrated by supershift (arrowhead) using a monoclonal antibody that recognizes ERalpha. In the middle lane, "PO" indicates probe only, and lacks proteins. (C) EMSA data as in (B), wherein supershift is noted using antibody specific for ERalpha but not when using antibodies for ERalpha tethering partners Sp1, c-Jun (a member of AP1 complexes), or ARP1/COUP-TFII. ERalpha-containing radioactive complexes are efficiently competed away by unlabeled ("cold") wild-type PCNA-ERE1 sequences (P-ERE1) but not with cold probe sequences mutated at the ERE-containing residues (P-ERE1-mut).
###end p 27
###begin title 28
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 78 86 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
A predicted ERE sequence near the PCNA gene was capable of binding to ERalpha in vitro
###end title 28
###begin p 29
###xml 397 401 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Krikun1">[60]</xref>
###xml 473 481 453 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 549 558 525 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g003">Figure 3B</xref>
###xml 850 859 822 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g003">Figure 3C</xref>
###xml 861 865 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Klinge2">[61]</xref>
###xml 866 870 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Safe1">[63]</xref>
###xml 954 963 926 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g003">Figure 3B</xref>
###xml 354 359 <span type="species:ncbi:9606">human</span>
We performed electrophoretic mobility shift assays (EMSA) using the radiolabeled PCNA-ERE1 sequence with recombinant ERalpha protein. In order to promote receptor-DNA binding, and to control for the presence or absence of ERalpha protein, recombinant ERalpha was combined with cofactors present in nuclear extracts from an ERalpha-negative, immortalized human endometrial stromal cell (HESC) line [60]. ERalpha-containing protein complexes were shown to bind to PCNA-ERE1, in vitro, as evidenced by supershift with an antibody specific for ERalpha (Figure 3B). No estrogen receptor-containing complex was noted from HESC cell extracts alone (not shown). No supershift was noted using antibodies targeting the transcription factors Sp1, AP-1 or ARP-1/COUP-TF2, although these factors have been demonstrated to bind with ERalpha at selected promoters (Figure 3C) [61]-[63]. Binding was weaker for PCNA-ERE1 than that observed for a consensus ERE sequence (Figure 3B) but stronger than that observed with PCNA-ERE2, for which binding was weakly detectable (not shown).
###end p 29
###begin p 30
###xml 282 291 278 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g003">Figure 3C</xref>
###xml 390 393 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 428 432 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 542 550 534 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 630 634 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Klinge1">[53]</xref>
###xml 727 731 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Deschenes1">[64]</xref>
###xml 733 737 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Martinez1">[65]</xref>
ERalpha-dependent binding to radiolabeled PCNA-ERE1 could be competed away using excess unlabeled ("cold") PCNA-ERE1 probe (P-ERE1) whereas a similar probe with mutations in the two half-sites of the ERE (P-ERE1mut) did not efficiently compete for labeled PCNA-ERE1-bound receptor (Figure 3C). These data suggested that one or both of these putative EREs might represent ERalpha-responsive cis-regulatory elements that modulate PCNA gene expression in MCF7 cells. It is recognized that the affinity of receptor binding to an ERE, as measured in vitro, need not correlate with the potency of the enhancer function that is observed [53] and that multiple EREs can work cooperatively in order to enhance target gene transcription [64], [65].
###end p 30
###begin title 31
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
Two ERE sequences near the PCNA gene did not enhance reporter expression in response to E2 treatment
###end title 31
###begin p 32
###xml 135 143 135 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 309 317 309 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g004">Figure 4</xref>
###xml 706 710 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Shang1">[66]</xref>
We cloned genomic fragments corresponding to each PCNA-ERE into luciferase reporter constructs and tested these for enhancer function, in vitro. Surprisingly, neither an 822 bp fragment containing PCNA-ERE1 nor a 551 bp fragment containing PCNA-ERE2 demonstrated E2-inducible enhancer function in MCF7 cells (Figure 4). Similar results were obtained when these constructs were tested with co-expressed ERalpha in HESC cells (which do not express endogenous ERalpha but respond to E2 when made to express ERalpha (not shown)). Thus, changing the cell type in which we tested the reporter constructs, and presumably the cohort of available transcription factor co-regulatory proteins within the cell nucleus [66], failed to indicate enhancer function for the putative ERE sequences being tested.
###end p 32
###begin title 33
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
Two EREs near PCNA do not enhance expression of a reporter in response to estrogen.
###end title 33
###begin p 34
The 822 bp genomic fragment containing PCNA-ERE1 and the 551 bp genomic fragment containing PCNA-ERE2 do not enhance luciferase reporter activity in response to E2. Two tandem copies of the isolated 15 bp ERE sequence found within PCNA-ERE1 (2xPCNA-ERE1) or PCNA-ERE2 (2xPCNA-ERE2) did not enhance reporter activity in response to E2. When these tandem ERE sequences were mutated to produce perfect 13 bp core consensus ERE sequences (Delta-2xPCNA-ERE1 and Delta-2xPCNA-ERE2) they produced E2-dependent enhancement of reporter activity in MCF7 cells. Values are the average of three experiments, performed in triplicate, with SEM indicated. * P < 0.002 comparing E2-treated with control.
###end p 34
###begin p 35
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 635 638 635 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 702 710 702 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Luciferase reporter assays that use single copy response elements are sometimes weakly responsive to transcription factors. Further, the function of any cloned enhancer region may be subject to inhibition by neighboring cis- and trans-regulatory elements, depending upon the length of DNA that is cloned and the inclusion or exclusion of such regulatory elements in the reporter construct. This phenomenon could produce false-negative observations in luciferase reporter assays that would depend, in part, upon the size of the genomic fragment that is employed in the assay. It is, therefore, common to assay multiple tandem copies of cis-regulatory elements in order to demonstrate enhancer function, in vitro.
###end p 35
###begin p 36
###xml 380 388 380 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g004">Figure 4</xref>
###xml 591 599 583 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g004">Figure 4</xref>
###xml 740 749 732 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona fide</italic>
###xml 957 961 945 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
We engineered luciferase reporter constructs with two tandem copies of the 15 bp PCNA-ERE1 sequence or two copies of the PCNA-ERE2 sequence (2xPCNA-ERE1 and 2xPCNA-ERE2), to test these isolated sequences for enhancer activity. As seen with the larger ERE-containing genomic fragments, the 2x tandem ERE sequences did not demonstrate E2-responsive enhancer function in MCF7 cells (Figure 4). When each tandem ERE sequence was mutated by one nucleotide to conform to a perfect 13 bp consensus ERE (Delta-2xPCNA-ERE1 and Delta-2xPCNA-ERE2), strong E2-responsive enhancer function was observed (Figure 4). These results confirmed that the promoter-reporter construct, pGL2-promoter, is functional in response to E2 in MCF7 cells when harboring bona fide ERE enhancer sequences. Taken together, these data did not support the hypothesis that the putative EREs, each computationally detected, are likely to function as ERalpha-regulated enhancer elements for the PCNA gene in MCF7 cells.
###end p 36
###begin title 37
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 63 70 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Two ERE sequences near the PCNA gene were not bound by ERalpha in vivo
###end title 37
###begin p 38
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 158 166 158 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 306 314 306 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo,</italic>
###xml 716 720 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Nardulli1">[67]</xref>
###xml 721 725 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Wood2">[69]</xref>
In light of the fact that the ERE-like sequences near PCNA are nearly consensus EREs, and that PCNA gene expression is E2-responsive, we wondered whether the in vitro assays that we employed to detect enhancer function could have produced spurious results. It remained possible that the chromatin context, in vivo, might dictate enhancer function in ways not observed using plasmid DNA in reporter assays. Imperfect (i.e. non-consensus) EREs have been demonstrated to have function when optimally positioned with regards to target TSSs, wherein they can provide sufficient affinity for ERalpha binding, permit important DNA bending, and favor specific patterns of coregulator recruitment to the target gene promoter [67]-[69].
###end p 38
###begin p 39
###xml 113 117 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 511 515 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Carroll1">[44]</xref>
###xml 517 521 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Kwon1">[70]</xref>
###xml 523 527 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Lin1">[71]</xref>
Although we were unable to detect ERalpha binding to PCNA-ERE1 or PCNA-ERE2 using ChIP-on-chip in response to E2 [31], we reasoned that this result could reflect established limitations in the sensitivity of this microarray-based approach. When we compared our findings to other reports of genome-wide location analysis for ERalpha in MCF7 cells, we similarly found no evidence for recruitment of ERalpha to the PCNA gene locus using ChIP-on-chip or alternative genomic approaches such as ChIP-DSL and ChIP-PET [44], [70], [71]. Notably, the receptor location analysis work in these studies compared ERalpha target occupancy after chromatin immunoprecipitation using E2-treated cells relative to ERalpha occupancy of chromatin DNA prepared from cells not subjected to immunoprecipitation (i.e. sheared input). As such, the approaches were not optimally designed to detect changes in target occupancy that depend upon E2 exposure, which can be tested by comparing ChIP of untreated cells (vehicle-treated ChIP) with ChIP from E2-treated cells.
###end p 39
###begin p 40
###xml 256 264 248 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g005">Figure 5</xref>
###xml 389 396 381 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In toto</italic>
###xml 480 483 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 637 645 625 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g005">Figure 5</xref>
###xml 778 782 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Shang2">[72]</xref>
In order to test for E2-dependent binding of ERalpha to PCNA-ERE1 or PCNA-ERE2, we performed ChIP-PCR using primers that span each putative ERE. Using ChIP-PCR, we were unable to demonstrate recruitment of ERalpha to either putative ERE in response to E2 (Figure 5). Similar results were obtained using multiple alternative PCR primer pairs targeting the same genomic regions (not shown). In toto, more than 3 primer pairs were used to evaluate ERalpha occupancy at each putative cis-element in response to E2; all demonstrated no evidence for receptor recruitment to the ERE sequences in response to hormone. The ChIP-PCR data shown in Figure 5 included a 45 min exposure to E2, a treatment that has been demonstrated to produce optimal ERalpha recruitment to target enhancers [72]. We obtained identical results with E2 treatments extended for 3 and 6 hours prior to protein crosslinking (not shown).
###end p 40
###begin title 41
###xml 60 68 56 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo,</italic>
ERalpha is not recruited to genomic PCNA-ERE1 or PCNA-ERE2, in vivo, after E2 exposure.
###end title 41
###begin p 42
###xml 517 521 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFF1</italic>
###xml 523 526 511 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 528 533 516 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GREB1</italic>
###xml 539 543 527 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTSD</italic>
###xml 739 743 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 788 795 768 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
MCF-7 cells were treated with or without E2 for 45 minutes, then ChIP was performed using antibodies against ERalpha. Quantitative PCR using genomic primers residing within 500 bp of the putative ERE sequences revealed no evidence that ERalpha is recruited to either putative ERE in response to E2 exposure. E2-stimulated ERalpha similarly failed to be enriched at an ERE-less locus (ERE-neg) that was also negative in prior ChIP-on-chip studies. Similar studies using genomic PCR primers for the E2-responsive genes TFF1, MYC, GREB1, and CTSD demonstrated rapid recruitment of ERalpha to these enhancer regions in response to E2. Also shown is ChIP-PCR validation of ERalpha-bound loci detected using ChIP-on-chip, as previously reported [31], targeting loci I20, J23, D54, and F15 (see methods section). Values are the average of three experiments, with SEM indicated. * P < 0.1 comparing E2-treated with control. ** P < 0.05 comparing E2-treated with control.
###end p 42
###begin p 43
###xml 225 233 221 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g005">Figure 5</xref>
###xml 347 351 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFF1</italic>
###xml 353 356 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 358 363 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GREB1</italic>
###xml 369 374 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTSD.</italic>
###xml 508 512 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 549 556 537 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">methods</xref>
###xml 581 589 569 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003523-g005">Figure 5</xref>
###xml 659 663 647 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 709 716 693 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
A genomic locus (chr7:72384008-72385027) that lacks an ERE and that failed to be detected using ChIP-on-chip (dubbed ERE-neg) also failed to be enriched for ERalpha using ChIP-PCR when comparing control and E2-treated cells (Figure 5). By contrast, ChIP-PCR confirmed E2-dependent recruitment of ERalpha to several known genomic targets including TFF1, MYC, GREB1, and CTSD. In addition, ChIP-PCR confirmed E2-dependent recruitment of ERalpha to four targets that we previously identified using ChIP-on-chip [31], dubbed I20, J23, D54, and F15 (see methods for genomic locations) (Figure 5). These data suggest that neither of the putative EREs detected near PCNA binds to ERalpha in an E2-dependent fashion, in vivo, in MCF7 cells. Further, the data demonstrate a good correlation between our ChIP-on-chip datasets and ChIP-PCR datasets.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Feinberg1">[73]</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Lund1">[74]</xref>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Frasor1">[30]</xref>
###xml 515 519 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-SchultzNorton1">[33]</xref>
###xml 557 561 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 754 758 750 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 825 829 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Nair1">[75]</xref>
###xml 934 938 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 1005 1009 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Shimomura1">[76]</xref>
###xml 1107 1111 1103 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Beral1">[77]</xref>
###xml 38 49 <span type="species:ncbi:9606">participant</span>
###xml 421 428 <span type="species:ncbi:9606">patient</span>
###xml 958 963 <span type="species:ncbi:9606">human</span>
Our data show that PCNA, an essential participant in DNA replication, epigenetic programming, and a regulator of the cell cycle, is up-regulated by E2 exposure in MCF7 cells. Epigenetic alterations play critical roles in tumorigenesis and cancer progression [73], [74] and we recently demonstrated that high protein expression of the E2-responsive histone variant H2A.Z in primary breast tumors correlates with decreased patient survival [31]. It is attractive to consider, and previously has been postulated [30], [33], that the E2-dependent expression of PCNA is potentially important for the proliferation of a diversity of tissues and tumors. Nair and colleagues recently reported an ERalpha-dependent proliferative effect in which estrogen enhanced PCNA gene expression in cancers of the cervix but not in normal cervix [75]. E2 exposure is a well-recognized risk factor for cancer of the breast and endometrium, and E2 enhances PCNA gene expression in human myometrial and leiomyoma tissues as well [76]. Most-recently, E2-responsive tumor progression has been suggested for epithelial ovarian cancer [77].
###end p 45
###begin p 46
###xml 206 210 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Bourdeau1">[32]</xref>
###xml 228 236 224 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 282 286 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 471 474 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
Our data indicate that, in MCF7 cells, the E2 effect depends upon new gene transcription and translation and is blocked by the pure ERalpha-antagonist ICI 182,780. Although excellent computational analysis [32], and preliminary in vitro data (EMSA), suggested that the mechanism of PCNA gene regulation might include the function of ERE sequences in the 5' region of the gene, our testing of the most-likely sequence elements, using several approaches, failed to confirm cis-regulatory function in MCF7 cells.
###end p 46
###begin p 47
###xml 382 386 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Carroll1">[44]</xref>
###xml 545 549 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Laganiere1">[59]</xref>
###xml 551 555 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Carroll3">[78]</xref>
###xml 726 730 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Frasor1">[30]</xref>
###xml 732 736 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 1029 1033 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Carroll3">[78]</xref>
That a subset of ERalpha target genes may require the synthesis of additional cofactor(s) prior to becoming subject to receptor-mediated transcriptional regulation remained a possibility consistent with our preliminary gene expression data. Such a model has been observed for ERalpha gene targets that are repressed by ERalpha only after the induction of corepressor protein NRIP-1 [44]. Similarly, some genes targeted by ERalpha require the function of a chromatin modifier, FOXA1, prior to becoming subject to ERalpha-mediated transactivation [59], [78]. The observation that E2 engenders gene regulatory cascades that can be divided into temporal categories (i.e. immediate, early, and late responses) is well-demonstrated [30], [31]. These data indicate that some genes are poised for immediate regulation, others may represent downstream/indirect targets of ERalpha function, and still other gene targets may require the synthesis of cofactors to modify chromatin targets in preparation for the arrival of activated ERalpha [78]. Neither the timing of a transcriptional response (early vs. late) nor the sensitivity of the response to CHX can be taken as formal proof that a given response is direct (i.e. ERalpha-mediated) or indirect.
###end p 47
###begin p 48
###xml 153 161 153 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Norris1">[79]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Marks1">[80]</xref>
###xml 536 540 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 600 603 600 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 693 697 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 699 703 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Carroll1">[44]</xref>
###xml 705 709 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Kwon1">[70]</xref>
###xml 711 715 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Lin1">[71]</xref>
###xml 978 982 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
This report describes two ERE-like sequences upstream of an E2-responsive gene. Both sequences failed to demonstrate transcriptional regulatory function in vitro and in vivo in MCF7 cells. PCNA-ERE1 resides within a repetitive element (Alu-Sc) while PCNA-ERE2 does not. A single report described a functional Alu-ERE for the BRCA1 gene [79] which, on further inspection, was determined to be non-functional in MCF7 cells [80]. The reported ERE sequence in those studies is not the same as noted for PCNA-ERE1. Our results indicate that PCNA is regulated in response to E2 either indirectly, or via a cis-acting ERE not detected by several independent genome-wide location analyses for ERalpha [31], [44], [70], [71], and only after the synthesis of newly translated protein(s). Importantly, in addition to ChIP-on-chip approaches, two genome-wide location analyses utilized ChIP-PET and the sensitive ChIP-DSL approaches; all demonstrated no evidence for ERalpha recruitment to PCNA.
###end p 48
###begin p 49
###xml 227 231 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 422 426 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Xu1">[81]</xref>
###xml 559 563 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Stender1">[82]</xref>
###xml 565 569 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Ren1">[83]</xref>
###xml 586 590 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 623 627 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Huang1">[84]</xref>
###xml 758 762 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 912 916 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 960 964 956 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 988 992 984 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Labrie2">[37]</xref>
###xml 1026 1030 1022 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 1076 1080 1072 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 66 72 <span type="species:ncbi:9606">humans</span>
Five members of the E2F family of transcription factors (of which humans have at least eight) are up-regulated by E2 in MCF7 cells although direct transcriptional regulation by ERalpha remains to be established for these genes [31]. Recent data suggests that E2F family members are capable of binding to identical sequences as homodimers or heterodimers (with DP family members) and may often subserve redundant functions [81]. Increasing data indicate that these factors play important roles in the E2-dependent cellular proliferation of breast cancer cells [82], [83]. E2F1 regulates PCNA gene expression in some systems [84]. We tested E2F1 using ChIP-PCR and found no evidence for E2-dependent recruitment of E2F1 to the transcription start sites of the PCNA gene (data not shown). Similar negative results were obtained when performing ChIP-PCR using antibodies for Sp1 or AP-1 in order to interrogate both PCNA ERE-like sequences and the two TSSs of the PCNA gene (not shown). ATF1 [37] and CREB1 are also regulators of PCNA gene expression but were not enriched at the PCNA promoter in MCF7 cells in genome-wide ChIP-chip analyses (S. Hua and K. White, manuscript in preparation).
###end p 49
###begin p 50
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA.</italic>
###xml 604 608 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 615 623 615 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003523.s002">Table S2</xref>
###xml 902 906 895 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
###xml 1026 1030 1019 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCNA</italic>
In order to identify alternative candidates that might mediate the estrogen response of PCNA in MCF7 cells, we undertook a computational analysis of predicted transcription factor binding sites in the two promoter regions for PCNA. These data were then correlated with gene expression data from our work, and from the work of others, cataloging estrogen-responsive transcription factors in MCF7 cells. The intersection of these datasets provides a list of estrogen-responsive transcription factors with high-confidence binding sites residing within two kilobases of each transcription start site for the PCNA gene (Table S2). In addition to E2F family members that warrant investigation (above), we have identified c/EBPbeta, FOXC1, FOXJ2, GATA-3, POU2F1/AP-2gamma, RARA, TFAP2C, and TFE3 as estrogen-responsive transcription factors with predicted binding sites in one or both promoter regions of the PCNA gene. Taken together, these data reveal good candidates for the mediator of the estrogenic cascade leading to enhanced PCNA gene expression in MCF7 cells. These candidates will be pursued in our future studies.
###end p 50
###begin p 51
###xml 610 614 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 616 620 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Carroll1">[44]</xref>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
Notably, approximately2310 perfect 13 bp consensus EREs (GGTCAnnnTGACC) exist within the human genome. Permitting just one nucleotide mismatch from the consensus sequence reveals nearly 50,000 ERE-like sites throughout the human genome. Our ChIP-on-chip data, supported by biological plausibility, suggest that the overwhelming majority of these sites are not functional in any given cell type. Two groups have used MCF7 cells to perform whole genome ChIP-on-chip for ERalpha location analysis, revealing between approximately1600-3700 receptor-bound loci in response to E2 (with considerable reproducibility) [31], [44]. Analysis of the highest-confidence ChIP sites, the 1017 sites that are common to both datasets, indicates that more than 90% of the ERE-like sequences at these loci are not perfect consensus sequences. Further, these datasets indicate that, most likely, <5-10% of perfect consensus ERE sites in the genome are ERalpha-bound in response to E2 in MCF7 cells.
###end p 51
###begin p 52
###xml 401 404 397 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 533 536 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 565 572 561 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 572 576 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Bourdeau1">[32]</xref>
###xml 578 582 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Kamalakaran1">[85]</xref>
###xml 583 587 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Tang1">[87]</xref>
###xml 635 642 631 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 723 726 719 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 432 437 <span type="species:ncbi:9606">human</span>
The chromatin and cellular determinants of ERalpha binding to enhancer elements remain to be fully established. This issue raises a cautionary note when drawing conclusions based upon computational analyses of genomic sequence which, even when evolutionarily conserved, will present hypotheses that must be validated by formal molecular biological testing. We conclude that computational detection of cis-regulatory elements in the human genome, even when accompanied by appropriate gene expression data, cannot be taken as proof of cis-regulatory element function in vivo[32], [85]-[87]. Each element must be tested, preferably using in vivo assays such as ChIP-PCR and chromatin conformation capture, in order to confirm cis-element function in any given cell type and cell context.
###end p 52
###begin title 53
Materials and Methods
###end title 53
###begin title 54
Cell Culture
###end title 54
###begin p 55
###xml 42 46 42 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Carroll3">[78]</xref>
###xml 764 768 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Krikun1">[60]</xref>
###xml 174 178 <span type="species:ncbi:9913">calf</span>
###xml 565 570 <span type="species:ncbi:9606">Human</span>
MCF7 cells (ATCC) were grown as described [78]. Cells were changed to estrogen-depleted, phenol-free media consisting of MEM alpha (Gibco) with 10% charcoal/dextran-stripped calf serum, insulin (4 microg/ml, Sigma), penicillin G, streptomycin, and L-glutamine (all Gibco), for 72 hours prior to treatments. Where indicated, treatments included vehicle control (100% EtOH), estradiol (10 nM or 100 nM, Sigma), actinomycin D (ActD, 2 microg/mL, Sigma), cycloheximide (CHX, 25 microg/mL, Sigma), and ICI 182,780 (1 microM, Tocris Biosciences). Telomerase-immortalized Human Endometrial Stromal Cells (HESC cells), a generous gift from Dr. Graciela Krikun, were grown in the same media used for the MCF7 cells. HESC cells have normal chromosome numbers and structures [60].
###end p 55
###begin title 56
Preparation of Nuclear Extracts and EMSA
###end title 56
###begin p 57
###xml 886 888 854 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1509 1517 1461 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003523.s001">Table S1</xref>
HESC nuclear extracts (NE) were purified using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce) according to the manufacturer's instructions. HESC cells have no demonstrable ERalpha activity using sensitive luciferase reporter assays and no ERalpha protein detected by Western blot analysis (data not shown). However, HESC cell nuclei have cofactors that promote the binding of recombinant ERalpha to target DNA in EMSA and these factors enhance binding when compared to recombinant ERalpha alone (rERalpha, Affinity Bioreagents). EMSA experiments were therefore conducted using HESC nuclear extracts combined with rERalpha. Protein determinations were performed using the Micro BCA assay (Pierce) and 5 microg of nuclear extract (with protease inhibitors, Roche) plus rERalpha (170 nM) was used in each lane of a 5% acrylamide gel in TBE buffer. Oligonucleotide probes were 32P-labeled using T4 Polynucleotide Kinase 5' End Label System (Promega) and purified using Mini Quick Spin Oligo Columns (Roche). Each radiolabeled probe was used at approximately200,000 cpm/lane and binding reactions included Tris-HCl pH 8.0 (25mM), KCl (50 mM), MgCl2 (6.25 mM), Glycerol (10%), DTT (0.5 mM) plus relevant antibody where indicated (400 ng/reaction): anti-ERalpha Ab-10 (LabVision), anti-cJun(N) sc-45 (Santa Cruz), anti Sp1 H-225 sc-14027 (Santa Cruz) and anti-ARP1/COUP-TFII (Santa Cruz). A complete list of oligonucleotide sequences used as probes for EMSA is presented in the supplementary materials (Table S1).
###end p 57
###begin title 58
RT-PCR
###end title 58
###begin p 59
###xml 158 160 154 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23</sub>
###xml 406 410 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTB</italic>
###xml 467 477 463 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTB, PCNA</italic>
###xml 479 483 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFF1</italic>
###xml 485 488 481 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 490 494 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STC2</italic>
###xml 500 504 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCC1</italic>
###xml 548 556 544 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003523.s001">Table S1</xref>
###xml 217 220 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
Total RNA was purified from cell lysates using Trizol reagent (Invitrogen). 2 microg of total RNA was used for reverse transcription using Anchored Oligo-(dT)23 (Sigma) as primer for 1st strand synthesis using the RT-AMV kit (Roche). 1:100 dilutions of cDNA were used as template for quantitative PCR using iQ-SYBR Green Master Mix (Biorad) in a Biorad Opticon 2 cycler. Q-RT-PCR values were normalized to ACTB mRNA levels for all samples. Primer pairs for RT-PCR of ACTB, PCNA, TFF1, MYC, STC2, and DCC1 are listed in the supplementary materials (Table S1).
###end p 59
###begin title 60
Western Blotting
###end title 60
###begin p 61
###xml 345 349 <span type="species:ncbi:9925">Goat</span>
###xml 355 360 <span type="species:ncbi:10090">mouse</span>
###xml 391 402 <span type="species:ncbi:3704">horseradish</span>
Cell lysates in 1% SDS lysis buffer were quantified using the Micro BCA Protein Assay Kit (Pierce), and 30 microg of total protein per well was separated by SDS-PAGE, transferred to PVDF membranes, and probed with antibodies against ACTIN (Sigma #A4700, used at 1:500 dilution) or PCNA (Cell Signaling #2586, used at 1:1000 dilution). Secondary Goat anti-mouse IgG antibody (conjugated with horseradish peroxidase) was incubated at a dilution of 1:10,000 and blots were developed using Amersham ECL Plus Western Blotting Detection Reagents (GE Healthcare).
###end p 61
###begin title 62
Chromatin Immunopreciptation (ChIP)-PCR
###end title 62
###begin p 63
###xml 43 47 43 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Hua1">[31]</xref>
###xml 283 287 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Shang2">[72]</xref>
###xml 289 293 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003523-Carroll3">[78]</xref>
###xml 312 313 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1042 1050 1016 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003523.s001">Table S1</xref>
ChIP was performed as previously described [31]. Briefly, MCF7 Cells were E2-deprived for 3 days (details above) and then treated with 10 nM E2 or vehicle (45 minutes) at 80% confluence. 45 minutes of E2 exposure has been demonstrated to produce maximal ERalpha binding to chromatin [72], [78]. approximately5x106 cells per ChIP were cross-linked with 1% formaldehyde for 10 minutes at 37degreesC then quenched with 125 mM glycine. The cells were washed with cold PBS and scraped into PBS with protease inhibitors (Roche). Cell pellets were resuspended in ChIP lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl (pH 8.1) and sonicated (Fisher Sonic Dysmembrinator) to produce sheared chromatin with average length 500 bp. The sheared chromatin was submitted to a clarification spin and the supernatant then used for ChIP or reserved as "Input." Antibodies used were anti-ERalpha (Ab-1, Ab-3, and AB-10 from Lab Vision and MC-20 from Santa Cruz). Forward and reverse primer sequences used for ChIP-PCR are listed in the supplementary materials (Table S1).
###end p 63
###begin title 64
Luciferase Reporter Assays
###end title 64
###begin p 65
Luciferase reporter assays were performed using the Luciferase Assay System (Promega) according to the manufacturer's instructions. Potential regulatory elements were cloned into pGL2-Promoter (Promega) and transfected into MCF7 cells using the TransIT-LT1 Transfection Reagent (Mirus). Cotransfection with a beta-galactosidase expressing plasmid (Promega) enabled normalization of transfection efficiency across samples using a beta-galactosidase assay kit (Promega) according to the manufacturer's instructions.
###end p 65
###begin title 66
Cloning and Mutagenesis
###end title 66
###begin p 67
###xml 673 681 673 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003523.s001">Table S1</xref>
PCR cloning was performed using PCR amplification of genomic loci from HESC cell genomic DNA which was prepared using the Genomic DNA Extraction kit (Qiagen) according to the manufacturer's instructions. PCR products were ligated with the reporter construct pGL2-promoter (at 5'-KpnI+3'-XhoI sites) for use in Luciferase Reporter assays (Promega). Mutagenized reporter constructs were prepared using the Genetailor Site-Directed Mutagenesis System (Invitrogen) according to the manufacturer's instructions. All clones and subclones were confirmed by DNA sequencing. Primers used for genomic locus amplification and for subcloning are listed in the supplementary materials (Table S1).
###end p 67
###begin title 68
Statistics
###end title 68
###begin p 69
Comparisons between two groups were made using a two-tailed Student's t-test with P values indicated.
###end p 69
###begin title 70
Supporting Information
###end title 70
###begin p 71
Table of oligonucleotide primers used for cloning, mutagenesis, ChIP-PCR, RT-PCR, and EMSA.
###end p 71
###begin p 72
(0.04 MB XLS)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
Estrogen-responsive transcription factors with predicted binding sites at the 5'- and/or 3'-promoter regions for the PCNA gene.
###end p 74
###begin p 75
(0.06 MB XLS)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 101 106 <span type="species:ncbi:9606">human</span>
The authors are grateful to Drs. Graciela Krikun and Charles Lockwood for providing the immortalized human endometrial stromal cell line, and to Drs. Sujun Hua, Kevin P. White, Joshua R. Friedman, Neil Sidell, and Robert N. Taylor for scientific discussions.
###end p 77
###begin title 78
References
###end title 78
###begin article-title 79
###xml 64 68 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro.
###end article-title 79
###begin article-title 80
Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis.
###end article-title 80
###begin article-title 81
Proliferating cell nuclear antigen (PCNA): a dancer with many partners.
###end article-title 81
###begin article-title 82
The puzzle of PCNA's many partners.
###end article-title 82
###begin article-title 83
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1.
###end article-title 84
###begin article-title 85
PCNA clamp facilitates action of DNA cytosine methyltransferase 1 on hemimethylated DNA.
###end article-title 85
###begin article-title 86
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human proliferating Cell nuclear antigen regulates transcriptional coactivator p300 activity and promotes transcriptional repression.
###end article-title 86
###begin article-title 87
PCNA, the maestro of the replication fork.
###end article-title 87
###begin article-title 88
Growth regulation of the PCNA gene.
###end article-title 88
###begin article-title 89
###xml 90 95 <span type="species:ncbi:9606">human</span>
An E2F site in the 5'-promoter region contributes to serum-dependent up-regulation of the human proliferating cell nuclear antigen gene.
###end article-title 89
###begin article-title 90
###xml 52 57 <span type="species:ncbi:9606">human</span>
In vivo structure of two divergent promoters at the human PCNA locus. Synthesis of antisense RNA and S phase-dependent binding of E2F complexes in intron 1.
###end article-title 90
###begin article-title 91
Regulation of proliferating cell nuclear antigen during the cell cycle.
###end article-title 91
###begin article-title 92
A conserved region in intron 1 negatively regulates the expression of the PCNA gene.
###end article-title 92
###begin article-title 93
Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors.
###end article-title 93
###begin article-title 94
###xml 28 33 <span type="species:ncbi:9606">human</span>
Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins.
###end article-title 94
###begin article-title 95
Interleukin 2-induced expression of proliferating cell nuclear antigen is regulated by transcriptional and post-transcriptional mechanisms.
###end article-title 95
###begin article-title 96
###xml 34 39 <span type="species:ncbi:9606">human</span>
Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
###end article-title 96
###begin article-title 97
###xml 58 63 <span type="species:ncbi:9606">human</span>
Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53.
###end article-title 97
###begin article-title 98
Transcriptional and posttranscriptional regulation of the proliferating cell nuclear antigen gene.
###end article-title 98
###begin article-title 99
###xml 14 18 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Effect of the SV40 T antigen on the posttranscriptional regulation of the proliferating cell nuclear antigen and DNA polymerase-alpha genes.
###end article-title 99
###begin article-title 100
###xml 133 138 <span type="species:ncbi:9606">human</span>
Prognostic value of the combined assessment of proliferating cell nuclear antigen immunostaining and nuclear DNA content in invasive human mammary carcinomas.
###end article-title 100
###begin article-title 101
Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer.
###end article-title 101
###begin article-title 102
Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
###end article-title 102
###begin article-title 103
Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.
###end article-title 103
###begin article-title 104
Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer.
###end article-title 104
###begin article-title 105
###xml 69 77 <span type="species:ncbi:9606">patients</span>
The prognostic significance of proliferating cell nuclear antigen in patients with lymph node-positive breast cancer.
###end article-title 105
###begin article-title 106
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer.
###end article-title 106
###begin article-title 107
Estrogen carcinogenesis in breast cancer.
###end article-title 107
###begin article-title 108
###xml 64 69 <span type="species:ncbi:9606">human</span>
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.
###end article-title 108
###begin article-title 109
Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression.
###end article-title 109
###begin article-title 110
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
Genome-wide identification of high-affinity estrogen response elements in human and mouse.
###end article-title 110
###begin article-title 111
Interaction of estrogen receptor alpha with proliferating cell nuclear antigen.
###end article-title 111
###begin article-title 112
The proliferating cell nuclear antigen regulates retinoic acid receptor transcriptional activity through direct protein-protein interaction.
###end article-title 112
###begin article-title 113
###xml 59 64 <span type="species:ncbi:9606">human</span>
A complex promoter element mediates transactivation of the human proliferating cell nuclear antigen promoter by the 243-residue adenovirus E1A oncoprotein.
###end article-title 113
###begin article-title 114
###xml 80 85 <span type="species:ncbi:9606">human</span>
The adenovirus E1A 12S product displays functional redundancy in activating the human proliferating cell nuclear antigen promoter.
###end article-title 114
###begin article-title 115
###xml 102 107 <span type="species:ncbi:9606">human</span>
Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter.
###end article-title 115
###begin article-title 116
###xml 53 58 <span type="species:ncbi:9606">human</span>
Involvement of RFX1 protein in the regulation of the human proliferating cell nuclear antigen promoter.
###end article-title 116
###begin article-title 117
###xml 92 97 <span type="species:ncbi:9606">human</span>
Transcriptional coactivator cAMP response element binding protein mediates induction of the human proliferating cell nuclear antigen promoter by the adenovirus E1A oncoprotein.
###end article-title 117
###begin article-title 118
###xml 18 23 <span type="species:ncbi:9606">human</span>
Regulation of the human proliferating cell nuclear antigen promoter by the adenovirus E1A-associated protein p107.
###end article-title 118
###begin article-title 119
Functional analysis of p53 binding under differential stresses.
###end article-title 119
###begin article-title 120
Long-range intrachromosomal interactions in the T helper type 2 cytokine locus.
###end article-title 120
###begin article-title 121
Defining a genomic radius for long-range enhancer action: duplicated conserved non-coding elements hold the key.
###end article-title 121
###begin article-title 122
Genome-wide analysis of estrogen receptor binding sites.
###end article-title 122
###begin article-title 123
Nuclear receptor-enhanced transcription requires motor- and LSD1-dependent gene networking in interchromatin granules.
###end article-title 123
###begin article-title 124
Preventing re-replication of chromosomal DNA.
###end article-title 124
###begin article-title 125
###xml 65 68 <span type="species:ncbi:10116">rat</span>
Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus.
###end article-title 125
###begin article-title 126
###xml 63 68 <span type="species:ncbi:9606">human</span>
Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor.
###end article-title 126
###begin article-title 127
Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells.
###end article-title 127
###begin article-title 128
###xml 89 94 <span type="species:ncbi:9606">human</span>
Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer.
###end article-title 128
###begin article-title 129
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome.
###end article-title 129
###begin article-title 130
Mechanism of estrogen activation of c-myc oncogene expression.
###end article-title 130
###begin article-title 131
Estrogen receptor interaction with estrogen response elements.
###end article-title 131
###begin article-title 132
Genomic targets of nuclear estrogen receptors.
###end article-title 132
###begin article-title 133
Anatomy of the estrogen response element.
###end article-title 133
###begin article-title 134
Diversity in the mechanisms of gene regulation by estrogen receptors.
###end article-title 134
###begin article-title 135
Interaction of estrogen receptors alpha and beta with estrogen response elements.
###end article-title 135
###begin article-title 136
Estrogen receptor target gene: an evolving concept.
###end article-title 136
###begin article-title 137
Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
###end article-title 137
###begin article-title 138
###xml 21 26 <span type="species:ncbi:9606">human</span>
A novel immortalized human endometrial stromal cell line with normal progestational response.
###end article-title 138
###begin article-title 139
###xml 0 7 <span type="species:ncbi:9031">Chicken</span>
Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression.
###end article-title 139
###begin article-title 140
The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.
###end article-title 140
###begin article-title 141
Nuclear receptor-mediated transactivation through interaction with Sp proteins.
###end article-title 141
###begin article-title 142
Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20 kb of upstream flanking sequences.
###end article-title 142
###begin article-title 143
Cooperative binding of estrogen receptor to imperfect estrogen-responsive DNA elements correlates with their synergistic hormone-dependent enhancer activity.
###end article-title 143
###begin article-title 144
Molecular determinants for the tissue specificity of SERMs.
###end article-title 144
###begin article-title 145
Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters.
###end article-title 145
###begin article-title 146
Estrogen response elements function as allosteric modulators of estrogen receptor conformation.
###end article-title 146
###begin article-title 147
Allosteric modulation of estrogen receptor conformation by different estrogen response elements.
###end article-title 147
###begin article-title 148
###xml 94 99 <span type="species:ncbi:9606">human</span>
Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters.
###end article-title 148
###begin article-title 149
Whole-genome cartography of estrogen receptor alpha binding sites.
###end article-title 149
###begin article-title 150
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.
###end article-title 150
###begin article-title 151
###xml 36 41 <span type="species:ncbi:9606">human</span>
The epigenetic progenitor origin of human cancer.
###end article-title 151
###begin article-title 152
Epigenetics and cancer.
###end article-title 152
###begin article-title 153
Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation.
###end article-title 153
###begin article-title 154
###xml 110 115 <span type="species:ncbi:9606">human</span>
Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma.
###end article-title 154
###begin article-title 155
###xml 62 67 <span type="species:ncbi:9606">Women</span>
Ovarian cancer and hormone replacement therapy in the Million Women Study.
###end article-title 155
###begin article-title 156
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.
###end article-title 156
###begin article-title 157
Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers.
###end article-title 157
###begin article-title 158
BRCA1 expression is not directly responsive to estrogen.
###end article-title 158
###begin article-title 159
A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.
###end article-title 159
###begin article-title 160
###xml 36 41 <span type="species:ncbi:9606">Human</span>
Estrogen Regulated Gene Networks in Human Breast Cancer Cells: Involvement of E2F1 in the Regulation of Cell Proliferation.
###end article-title 160
###begin article-title 161
E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints.
###end article-title 161
###begin article-title 162
Identification of an essential cis-element near the transcription start site for transcriptional activation of the proliferating cell nuclear antigen gene.
###end article-title 162
###begin article-title 163
Identification of estrogen-responsive genes using a genome-wide analysis of promoter elements for transcription factor binding sites.
###end article-title 163
###begin article-title 164
Identifying estrogen receptor alpha target genes using integrated computational genomics and chromatin immunoprecipitation microarray.
###end article-title 164
###begin article-title 165
Computational method for discovery of estrogen responsive genes.
###end article-title 165
###begin p 166
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 166
###begin p 167
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: CBK is supported by a grant from the Research Scientist Development Program (NIH-5K12HD00849) and by the Society for Gynecologic Investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 167

